Indazole compounds as B3 adrenoceptor agonist

Details Indazole compounds as B3 adrenoceptor agonist Indazole compounds as B3 adrenoceptor agonist

2007-10-30

2009-10-06

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S300100

Reexamination Certificate

active

07598284

ABSTRACT:
Compounds of the general formula (I):or a salt thereof, wherein R1is a hydrogen atom or the like; R2is NHSO2R3or the like; R3is a (C1-C6)alkyl group or the like; R5is a hydrogen atom or the like; R6and R7may be the same or different and are each independently a hydrogen atom or the like; X is an oxygen atom or the like; Y is an oxygen atom or the like; Z1to Z6are a carbon atom or the like; n is an integer of 0 to 6; *1 is an asymmetric carbon atom; and *2 is an asymmetric carbon atom when R5is other than a hydrogen atom.

REFERENCES:
patent: 4378361 (1983-03-01), Schromm et al.
patent: 5767133 (1998-06-01), Dow et al.
patent: 5859044 (1999-01-01), Dow et al.
patent: 6037362 (2000-03-01), Miyoshi et al.
patent: 6172099 (2001-01-01), Miyoshi et al.
patent: 6495701 (2002-12-01), Matsubara et al.
patent: 6861444 (2005-03-01), Ikuta et al.
patent: 7271190 (2007-09-01), Miyoshi et al.
patent: 2003/0040538 (2003-02-01), Miyoshi et al.
patent: 2003/0191174 (2003-10-01), Ikuta et al.
patent: 2004/0102437 (2004-05-01), Takami et al.
patent: 2004/0138286 (2004-07-01), Imazaki et al.
patent: 2429253 (1974-06-01), None
patent: 26 51 572 (1977-06-01), None
patent: 0008653 (1980-03-01), None
patent: 0 023 385 (1981-02-01), None
patent: 0 171 702 (1986-02-01), None
patent: 0 455 006 (1991-04-01), None
patent: 659 737 (1995-06-01), None
patent: 1174425 (2000-03-01), None
patent: 1565080 (1976-11-01), None
patent: 55-53262 (1980-04-01), None
patent: 58-41860 (1983-03-01), None
patent: 8-165276 (1996-06-01), None
patent: WO 94/29290 (1994-12-01), None
patent: WO 95/29159 (1995-11-01), None
patent: 96/35670 (1996-11-01), None
patent: 97/25311 (1997-07-01), None
patent: 9901431 (1999-01-01), None
patent: WO 00/35890 (2000-06-01), None
patent: 00/59287 (2000-10-01), None
patent: 00/59885 (2000-10-01), None
patent: 01/56988 (2001-08-01), None
patent: 01/83451 (2001-11-01), None
patent: WO 01/83452 (2001-11-01), None
patent: WO 01/83453 (2001-11-01), None
patent: 02/100833 (2002-12-01), None
Patani et al., Chem Rev, 1996, vol. 96 (8), pp. 3147-3176.
Arch et al., “Atypical B-adrenoceptor on brown adipocytes as target for anti-obesity drugs”, Nature, vol. 309, May 1984, pp. 163-165.
Arch et al., “Prospects for B3-adrenoceptor agonists in the treatment of obesity and diabetes”, international Journal of Obesity, 1996, vol. 20, pp. 191-199.
Largis et al., “Antidiabetic and Antiobesity Effects of a Highly Selective B3-Adrenoceptor Agonist (CL 316,243)”, Drug Development Research, 1994, vol. 32, pp. 69-76.
Fisher et al., “A Selective Human B3Adrenergic Receptor Agonist Increases Metabolic Rate in Rhesus Monkeys”, J. Clin. Invest., 1998, vol. 101, pp. 2387-2393.
Fujimura et al., “Expression and Possible Functional Role of the B3-Adrenoceptor in Human and Rat Detrusor Muscle”, The Journal of Urology, 1999, vol. 161, pp. 680-685.
Takeda et al., “Evidence for B3-Adrenoceptor Subtypes in Relaxation of the Human Urinary Bladder Detrusor: Analysis by Molecular Biological and Pharmacological Methods”, The Journal of Pharmacology and Experimental Therapeutics, 1999, vol. 288, pp. 1367-1373.
Cantello et al., “BRL 35135”, Drugs of the Future, 1991, vol. 16, pp. 797-800.
Humber et al., “Disodium . . . A Potent B-Adreneric Agonist Virtually Specific for B3Receptors. A Promising Antidiabetic and Antiobesity Agent”, J. Med. Chem, 1992, vol. 35, pp. 3081-3084.

Affiliated with

Also associated with

Rating

Indazole compounds as B3 adrenoceptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazole compounds as B3 adrenoceptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compounds as B3 adrenoceptor agonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4060630